surprise surprise -
Disclosure: The study was funded in part by Merck.
of course not -
“there was no unusual pattern or clustering to the deaths that would suggest that they were caused by the vaccine.”
Meanwhile, Merck is benefitting tremendously from vaccine sales. The vaccine is expected to reach $1 billion in sales next year, and could reach more than $4 billion in sales in five years, according to Wall Street analysts.